Hashtag search | TOKERO

Revier Therapeutics, a Heidelberg-based #BioTech company advancing disease-modifying #therapies for patients with #cardiometabolic disease, has launched and closed a €6 million #Seed financing round. 🇩🇪🫀🧬💊

https://t.co/3QBkCY4tfE

3

You’ve reached the end 🎉